DK1440148T3 - Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår - Google Patents

Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår

Info

Publication number: DK1440148T3
Authority: DK; Denmark
Prior art keywords: keratinocytes; wounds; useful; treatment; biologically active
Prior art date: 2001-10-17

Application number

DK02781248.6T

Other languages

English (en)

Inventor

Petra Eberhardt

Wolfgang Noe

Katharina Reif

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-17

Filing date

2002-10-14

Publication date

2010-09-27

2002-10-14 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2010-09-27 Application granted granted Critical

2010-09-27 Publication of DK1440148T3 publication Critical patent/DK1440148T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Botany (AREA)
Hematology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Materials For Medical Uses (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK02781248.6T 2001-10-17 2002-10-14 Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår DK1440148T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10151296A DE10151296A1 (de)	2001-10-17	2001-10-17	Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
PCT/EP2002/011459 WO2003033686A2 (de)	2001-10-17	2002-10-14	Keratinozyten verwendbar als biologisch aktive substanz bei der behandlung von wunden

Publications (1)

Publication Number	Publication Date
DK1440148T3 true DK1440148T3 (da)	2010-09-27

Family

ID=7702826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02781248.6T DK1440148T3 (da)	2001-10-17	2002-10-14	Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår

Country Status (30)

Country	Link
US (3)	US7247478B2 (da)
EP (1)	EP1440148B1 (da)
JP (1)	JP4476625B2 (da)
KR (1)	KR101019916B1 (da)
CN (1)	CN100432220C (da)
AR (1)	AR036827A1 (da)
AT (1)	ATE474039T1 (da)
AU (1)	AU2002349352B2 (da)
BR (1)	BR0213282A (da)
CA (1)	CA2461141C (da)
CO (1)	CO5580844A2 (da)
DE (2)	DE10151296A1 (da)
DK (1)	DK1440148T3 (da)
EA (1)	EA009073B1 (da)
EC (1)	ECSP045065A (da)
ES (1)	ES2345767T3 (da)
HR (1)	HRP20040347B1 (da)
HU (1)	HU228887B1 (da)
IL (2)	IL161442A0 (da)
MX (1)	MXPA04003487A (da)
MY (1)	MY137828A (da)
NO (1)	NO334974B1 (da)
NZ (1)	NZ532899A (da)
PE (1)	PE20030627A1 (da)
PL (1)	PL367338A1 (da)
RS (1)	RS30104A (da)
UA (1)	UA81398C2 (da)
UY (1)	UY27486A1 (da)
WO (1)	WO2003033686A2 (da)
ZA (1)	ZA200402306B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2005012492A2 (en) *	2003-08-01	2005-02-10	Stratatech Corporation	Human skin equivalents expressing exogenous polypeptides
WO2006010161A2 (en) *	2004-07-20	2006-01-26	The Regents Of The University Of California	In vitro wound healing assay and device
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
CN102838599A (zh)	2006-05-04	2012-12-26	贝林格尔.英格海姆国际有限公司	多晶型
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
US8080223B2 (en) *	2007-10-19	2011-12-20	Biointraface, Inc.	Method of making a composite from metal oxide and polymer precursors
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
EP2303293A1 (en)	2008-05-27	2011-04-06	Pluristem Ltd.	Methods of treating inflammatory colon diseases
KR20200118243A (ko)	2008-08-06	2020-10-14	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru)	2008-12-23	2015-12-30	Бёрингер Ингельхайм Интернациональ Гмбх	Солевые формы органического соединения
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en)	2009-11-27	2014-11-28	Boehringer Ingelheim Int	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en)	2010-05-05	2011-11-10	Boehringer Ingelheim International Gmbh	Combination therapy
EP2711422B1 (en) *	2010-06-09	2014-10-01	Chanel Parfums Beauté	Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
NZ603319A (en)	2010-06-24	2015-04-24	Boehringer Ingelheim Int	Diabetes therapy
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en)	2011-07-15	2020-06-23	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
EP3685839A1 (en)	2012-05-14	2020-07-29	Boehringer Ingelheim International GmbH	Linagliptin for use in the treatment of albuminuria and kidney related diseases
US20130303554A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in sirs and/or sepsis
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2013174769A1 (en)	2012-05-25	2013-11-28	Boehringer Ingelheim International Gmbh	Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor
ES2950384T3 (es)	2014-02-28	2023-10-09	Boehringer Ingelheim Int	Uso médico de un inhibidor de DPP-4
CN105219697A (zh) *	2014-07-04	2016-01-06	赫柏慧康生物科技无锡有限公司	一种人原代角质细胞分离制备的方法
EP3132809A1 (en)	2015-08-21	2017-02-22	Bioskinco GmbH	Composition and products comprising senescent cells for use in tissue regeneration
US10668259B2 (en)	2015-10-21	2020-06-02	Materials Science Associates, LLC	Metal oxide and polymer controlled delivery systems, sunscreens, treatments, and topical coating applicators
WO2017178472A1 (en) *	2016-04-12	2017-10-19	Unicyte Ev Ag	Isolation of extracellular vesicles (evs) from biological fluid samples
WO2017211979A1 (en)	2016-06-10	2017-12-14	Boehringer Ingelheim International Gmbh	Combinations of linagliptin and metformin
CN109055303A (zh) *	2018-09-12	2018-12-21	山东麦德克斯生物科技有限公司	一种皮肤组织的构建方法
RU2731065C1 (ru) *	2019-12-24	2020-08-28	Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН (ИБР РАН)	Состав криоконсерванта для длительного хранения первичных кератиноцитов

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4016038A (en) *	1968-04-01	1977-04-05	Hayashibara Company	Process for preparing maltoses from starches
US4016036A (en) *	1975-11-14	1977-04-05	Massachusetts Institute Of Technology	Process for serially culturing keratinocytes
IT1207525B (it) *	1987-06-23	1989-05-25	Ist Naz Ric Sul Cancro	Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
US5292655A (en) *	1990-01-29	1994-03-08	Wille Jr John J	Method for the formation of a histologically-complete skin substitute
IT1248934B (it) *	1990-06-01	1995-02-11	Fidia Spa	Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US6585969B1 (en) *	1991-11-20	2003-07-01	N. V. Innogenetics S.A.	Non-viable keratinocyte cell composition or lysate for promoting wound healing
ATE307599T1 (de) *	1991-11-20	2005-11-15	Innogenetics Nv	Keratinozyt-abstammende granulate zur verwendung als wundheilendes mittel
US5891617A (en) *	1993-09-15	1999-04-06	Organogenesis Inc.	Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
US5518878A (en)	1993-09-15	1996-05-21	Organogenesis Inc.	Cryopreservation of cultured skin or cornea equivalents with agitation
US5693332C1 (en) *	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
AUPP244498A0 (en) *	1998-03-18	1998-04-09	Medvet Science Pty. Ltd.	Keratinocyte stem cells
DE19917532A1 (de)	1999-04-19	2000-10-26	Christian Toloczyki	Trägergebundene kultivierte Stamm-bzw. Vorläuferzellen von Keratinozyten

2001
- 2001-10-17 DE DE10151296A patent/DE10151296A1/de not_active Withdrawn
2002
- 2002-10-10 US US10/268,496 patent/US7247478B2/en not_active Expired - Fee Related
- 2002-10-14 DK DK02781248.6T patent/DK1440148T3/da active
- 2002-10-14 UY UY27486A patent/UY27486A1/es not_active Application Discontinuation
- 2002-10-14 KR KR1020047005677A patent/KR101019916B1/ko not_active Expired - Fee Related
- 2002-10-14 EP EP02781248A patent/EP1440148B1/de not_active Expired - Lifetime
- 2002-10-14 NZ NZ532899A patent/NZ532899A/en not_active IP Right Cessation
- 2002-10-14 BR BR0213282-6A patent/BR0213282A/pt not_active Application Discontinuation
- 2002-10-14 EA EA200400482A patent/EA009073B1/ru not_active IP Right Cessation
- 2002-10-14 HU HU0600341A patent/HU228887B1/hu not_active IP Right Cessation
- 2002-10-14 ES ES02781248T patent/ES2345767T3/es not_active Expired - Lifetime
- 2002-10-14 CA CA2461141A patent/CA2461141C/en not_active Expired - Fee Related
- 2002-10-14 JP JP2003536415A patent/JP4476625B2/ja not_active Expired - Fee Related
- 2002-10-14 RS YU30104A patent/RS30104A/sr unknown
- 2002-10-14 IL IL16144202A patent/IL161442A0/xx unknown
- 2002-10-14 UA UA20040503620A patent/UA81398C2/xx unknown
- 2002-10-14 WO PCT/EP2002/011459 patent/WO2003033686A2/de not_active Ceased
- 2002-10-14 DE DE50214540T patent/DE50214540D1/de not_active Expired - Lifetime
- 2002-10-14 HR HRP20040347AA patent/HRP20040347B1/xx not_active IP Right Cessation
- 2002-10-14 PL PL02367338A patent/PL367338A1/xx unknown
- 2002-10-14 AU AU2002349352A patent/AU2002349352B2/en not_active Ceased
- 2002-10-14 CN CNB028207874A patent/CN100432220C/zh not_active Expired - Fee Related
- 2002-10-14 AT AT02781248T patent/ATE474039T1/de active
- 2002-10-15 MY MYPI20023849A patent/MY137828A/en unknown
- 2002-10-15 PE PE2002001015A patent/PE20030627A1/es not_active Application Discontinuation
- 2002-10-16 AR ARP020103870A patent/AR036827A1/es unknown
2004
- 2004-03-24 ZA ZA200402306A patent/ZA200402306B/en unknown
- 2004-04-14 MX MXPA04003487A patent/MXPA04003487A/es active IP Right Grant
- 2004-04-15 EC EC2004005065A patent/ECSP045065A/es unknown
- 2004-04-15 IL IL161442A patent/IL161442A/en not_active IP Right Cessation
- 2004-04-16 CO CO04035176A patent/CO5580844A2/es not_active Application Discontinuation
- 2004-04-16 NO NO20041570A patent/NO334974B1/no not_active IP Right Cessation
2006
- 2006-11-03 US US11/556,367 patent/US7306943B2/en not_active Expired - Fee Related
2007
- 2007-10-31 US US11/930,880 patent/US7754481B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0600341A2 (en)	2006-08-28
US7247478B2 (en)	2007-07-24
HU228887B1 (hu)	2013-06-28
US20070065419A1 (en)	2007-03-22
CA2461141A1 (en)	2003-04-24
JP4476625B2 (ja)	2010-06-09
IL161442A (en)	2012-02-29
HUP0600341A3 (en)	2011-03-28
EP1440148A2 (de)	2004-07-28
CO5580844A2 (es)	2005-11-30
RS30104A (sr)	2006-10-27
HRP20040347A2 (en)	2005-04-30
CA2461141C (en)	2011-12-06
US7754481B2 (en)	2010-07-13
UA81398C2 (en)	2008-01-10
MXPA04003487A (es)	2004-07-30
DE50214540D1 (de)	2010-08-26
US20080131967A1 (en)	2008-06-05
IL161442A0 (en)	2004-09-27
AU2002349352B2 (en)	2007-11-01
AR036827A1 (es)	2004-10-06
US7306943B2 (en)	2007-12-11
KR20040045856A (ko)	2004-06-02
EA200400482A1 (ru)	2004-12-30
WO2003033686A2 (de)	2003-04-24
PL367338A1 (en)	2005-02-21
ATE474039T1 (de)	2010-07-15
NZ532899A (en)	2006-04-28
DE10151296A1 (de)	2003-04-30
NO334974B1 (no)	2014-08-11
BR0213282A (pt)	2004-10-26
WO2003033686A3 (de)	2004-02-12
EA009073B1 (ru)	2007-10-26
EP1440148B1 (de)	2010-07-14
JP2005505392A (ja)	2005-02-24
PE20030627A1 (es)	2003-07-16
ES2345767T3 (es)	2010-10-01
NO20041570L (no)	2004-04-16
KR101019916B1 (ko)	2011-03-08
ZA200402306B (en)	2006-05-31
HRP20040347B1 (en)	2012-07-31
MY137828A (en)	2009-03-31
ECSP045065A (es)	2004-05-28
CN100432220C (zh)	2008-11-12
US20030091542A1 (en)	2003-05-15
UY27486A1 (es)	2003-05-30
CN1571835A (zh)	2005-01-26

Publication	Publication Date	Title
NO20041570L (no)	2004-04-16	Keratinocyter som kan brukes som biologisk aktive substanser for behandling av sar
AU2002349352A1 (en)	2003-07-03	Keratinocytes which may be used as biologically active substances for the treatment of wounds
DE602004028359D1 (de)	2010-09-09	Reinigung von biologisch produziertem 1,3-propandiol
DK2412368T3 (da)	2013-11-04	Sammensætning til behandling af ar
DE60205514D1 (de)	2005-09-22	Wegwerfwindel
DK1169460T3 (da)	2006-09-18	Fremstilling af biologisk aktive molekyler
ATE512163T1 (de)	2011-06-15	Verabreichung von mitteln zur behandlung von entzündungen
DE60022785D1 (de)	2006-02-02	Modulare bandage
DE60223697D1 (de)	2008-01-03	Wegwerfwindel
DE60118550D1 (de)	2006-05-18	Neurotoxin implantat
PL358451A1 (pl)	2004-08-09	Sposób sterylizacji materiałów biologicznych
FI20001696L (fi)	2002-01-22	Biologisesti aktiivinen materiaali
ATE503461T1 (de)	2011-04-15	Pharmazeutische zusammensetzungen zur behandlung von asthma
DE60029737D1 (de)	2006-09-14	Wegwerfwindel
DE60136909D1 (de)	2009-01-22	Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
DE60223576D1 (de)	2007-12-27	Hautbehandlungszusammensetzung
PL356784A1 (pl)	2004-07-12	Substancja do zastosowania w leczeniu łuszczycy
DE60105927D1 (de)	2004-11-04	Wegwerfwindel
DE60232290D1 (de)	2009-06-25	Kontrollierte Auflösung von Wirkstoffen
EP1409454A4 (en)	2005-05-18	INCREASED BIOVERABILITY OF CAROTENOIDS
DE60105232D1 (de)	2004-10-07	Wegwerfwindel
FI20020360A0 (fi)	2002-02-25	Biologisesti aktiivisen tuotteen uusi käyttö
DE60129123D1 (de)	2007-08-09	BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
DE60230292D1 (de)	2009-01-22	Aktivsauerstoff erzeugendes material
DK1461042T3 (da)	2008-12-01	Anvendelse af desoxypeganin til behandling af klinisk depression